Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Growth in the quarter primarily due to higher sales in HIV as well as in Veklury (remdesivir), Oncology and Liver Disease.
November 8, 2024
By: Kristin Brooks
Managing Editor, Contract Pharma
Gilead 3Q Revenues: $7.5 billion (+7%) 3Q Earnings: $1.25 billion (-42%) YTD Revenues: $21.2 billion (+6%) YTD Loss: $1.3 billion (earnings were $4.4 billion YTD23) Comments: Growth in the quarter primarily due to higher sales in HIV as well as in Veklury (remdesivir), Oncology and Liver Disease. Biktarvy sales were up 13% to $3.5 billion in the quarter. Descovy sales were up 15% to $586 million. The Liver Disease portfolio sales increased 4% to $733 million in the quarter primarily driven by higher demand in viral hepatitis medicines. Veklury sales increased 9% to $692 million, primarily driven by increased rates of COVID-19 related hospitalizations, particularly in the U.S. Cell Therapy product sales were flat at $485 million in the quarter with Yescarta sales down 1% to $387 million and Tecartus sales up 2% to $98 million. Trodelvy sales increased 17% to $332 million. Earnings in the quarter were impacted by higher acquired IPR&D of $505 million primarily driven by a $320 million charge related to the buy-out of global Livdelzi royalties from Janssen Pharmaceutica NV, and tax expense with the effective tax rate of 31.1% in the third quarter 2024 compared to 6.3% in the same period in 2023.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !